Company Filing History:
Years Active: 2021
Title: **Werner Hasselwander: Innovator in Pharmaceutical Processes**
Introduction
Werner Hasselwander, based in Oberkirch, Germany, is a distinguished inventor known for his contributions to the pharmaceutical industry. With a focus on improving processes for drug production, his work plays a crucial role in enhancing the efficiency of medical treatments.
Latest Patents
Hasselwander holds one patent titled "Process to convert technical ascomycin into purified pimecrolimus." This innovative method offers an improved process for transforming crude ascomycin into purified pimecrolimus. The process involves chlorinating crude ascomycin with triphenylphosphine and N-chlorosuccinimide (NCS) to produce crude pimecrolimus, which is subsequently purified through high-pressure liquid chromatography (HPLC) and crystallization. This enhancement allows for the selective removal of close homologs of pimecrolimus without needing prior purification of the ascomycin starting material, making the conversion process more practical and cost-effective for industrial applications.
Career Highlights
Currently, Werner Hasselwander is associated with Meda AB, a reputable company in the pharmaceutical sector. His innovative work contributes to advancing medication manufacturing techniques, which can have a substantial impact on therapy accessibility and affordability.
Collaborations
Throughout his career, Hasselwander has worked alongside notable colleagues, including Borut Gabriel and Aljaz Kajtna. Their collaborative efforts have strengthened the innovations in drug processes and contributed to the pharmaceutical landscape.
Conclusion
In summary, Werner Hasselwander's inventive spirit and dedication to improving pharmaceutical processes demonstrate his significant role in modern medicine. His patent for converting ascomycin to pimecrolimus showcases a pivotal step toward making drug production more efficient, highlighting the importance of innovation in healthcare.